John A. Donofrio

John A. Donofrio - President

John joined EPI Health in March of 2019 and has over 25 years of experience in leading US and International teams in the pharmaceutical industry. Mr. Donofrio brings a proven track record of business, operations, strategic, and financial leadership to EPI Health. Most recently, Mr. Donofrio was Chief Financial Officer at TrialCard, a technology based pharmaceutical solutions company, that provides patient affordability, medication access and adherence, and patient support services. Prior to TrialCard, Mr. Donofrio was CFO and Head of Business Development for Merz North America, a leader in medical aesthetics, neurotoxins and dermatology. In addition to his executive positions, Mr. Donofrio spent over 20 years with GlaxoSmithKline in various US and international roles of increasing responsibility, including Global Vice President of finance for the global dermatology business unit, Stiefel, a GSK company. He is also a board member and audit chair for Aytu Bioscience, serves on the board of directors of the Children’s Skin Disease Foundation and Alliance Medical Ministries, and is a graduate of North Carolina State University, with a degree in Accounting.

Brett Fair

Brett Fair - VP, Commercial Operations and Strategy

Brett Fair is a seasoned pharmaceutical executive with more than 20 years of pharmaceutical commercialization and global business development experience. Most recently, Brett held the role of Chief Commercial Officer at Aclaris Therapeutics. Prior to joining Aclaris, Brett was the Vice President of Business Development at Aqua Pharmaceuticals, LLC. Prior to Aqua Pharmaceuticals, LLC, Brett held global commercial and business development roles at GlaxoSmithKline plc. He started his career at Allergan plc and held positions of increasing responsibility in sales and marketing.

Brett received his Bachelor of Science from the University of Delaware and his Master of Business Administration from the Graziadio School of Business and Management at Pepperdine University.

Robert Dougherty

Robert Dougherty - Vice President of Sales

Rob brings over 20 years of sales, marketing, and leadership experience in a number of therapeutic areas, most notably Dermatology. Prior to joining EPI Health, he was a founding member and National Sales Director of Promius Pharma, the branded dermatology division of Dr. Reddy's Laboratories. Previously, he was a Regional Sales Manager for Dermik Laboratories, a division of Sanofi Aventis, and a District Manager, National Sales Trainer, and Key Account Manager for Bertek Pharmaceuticals, a division of Mylan Laboratories. Throughout his career, Rob has been recognized for: developing high performing teams, fostering cultures of transparency, recognition, and communication, and leading his team to sales excellence.

Mike Vecchiolla

Mike Vecchiolla - Director, Medical and Professional Relations

Mike has over 25 years of experience in pharmaceuticals in several therapeutic areas including 15 years exclusively in dermatology.  Prior to joining EPI Health as Director of Medical and Professional Relations, Mike served in various Medical Affairs, Sales and Sales Management roles with a number Pharmaceutical companies including, Sun Pharmaceuticals, Ranbaxy, Inspire Pharmaceuticals, CollaGenex Pharmaceuticals and Burroughs Wellcome Pharmaceuticals.  Mike earned his BA in Biology at The University of North Carolina at Chapel Hill.  He and his wife Heather and their twin daughters, Maggie and Gracie live in Mount Pleasant SC.

JR Buzzelli

JR Buzzelli - Director, Marketing & Access

JR has over 25 years of commercial experience across ethical Rx, medical device, and OTC businesses. He brings an extensive track record for delivering results in marketing, sales management, access, finance and strategic management across multiple therapeutic areas including the last 13 years in Dermatology. Prior to joining EPI Health, JR worked as Director of Marketing and Access Solutions at PharmaDerm a Sandoz / Novartis Company. He was a critical part of the team that licensed and launched Kerydin in the US Dermatology marketplace. JR has achieved success throughout his career with Pharmacia, Organon, Johnson & Johnson, and Bayer in both sales and marketing. JR earned an MBA from The Wake Forest University School of Business and BS from The Darla Moore School of Business at The University of South Carolina.